US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on March 24 for "Methods for treatment of cancers harboring an H3K27M mutation" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,675, issued on March 24, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Methods for treatment of cancers harboring an H3K27M mutation" was invented by Michelle Monje-Deisseroth (Stanford, Calif.), Robbie Majzner (Stanford, Calif.), Crystal Mackall (Stanford, Calif.) and Christopher Mount (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to immunotherapeutic treatment of cancer. In particular, the invention relates to methods of treating cancer carrying a histone H3 K27M (H3K27M) mutation (e.g., diffuse midline glioma with H3K27M mutation) using immunotherapeut...